CMC Pharma Consulting BJ ApS

CVR number: 41988592
Rungsted Strandvej 215, 2960 Rungsted Kyst

Income statement (kDKK)

202120222023
Fiscal period length121212
Net sales
Gross profit3 524.025 176.344 949.67
Employee benefit expenses-2 715.09-4 683.53-4 759.45
Total depreciation-4.56
EBIT808.92492.81185.65
Other financial income6.8428.153.13
Other financial expenses-27.03-46.94-16.12
Pre-tax profit788.74474.02172.67
Income taxes- 177.52- 128.85-61.09
Net earnings611.22345.18111.57

Assets (kDKK)

202120222023
Intangible assets total
Machinery and equipment41.04
Tangible assets total41.04
Investments total
Long term receivables total
Inventories total
Current trade debtors656.35677.18519.61
Prepayments and accrued income191.1034.44
Current deferred tax assets26.91
Short term receivables total847.45711.62546.51
Cash and bank deposits289.5587.0926.58
Cash and cash equivalents289.5587.0926.58
Balance sheet total (assets)1 137.00798.71614.13

Equity and liabilities (kDKK)

202120222023
Share capital40.0040.0040.00
Shares repurchased600.00300.00120.00
Retained earnings- 600.00- 288.78-63.60
Profit of the financial year611.22345.18111.57
Shareholders equity total651.22396.40207.97
Non-current liabilities total
Current trade creditors14.5015.2017.85
Current owed to participating3.981.942.07
Short-term deferred tax liabilities177.52127.93
Other non-interest bearing current liabilities289.78257.25386.24
Current liabilities total485.78402.31406.16
Balance sheet total (liabilities)1 137.00798.71614.13
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.